The role of collagen type VI alpha 6 chain as a potential tumor suppressor in breast cancer: an immune regulation perspective
Abstract Background Collagen type VI alpha 6 chain (COL6A6), an essential component of epithelial cell basal lamina, is hypothesized to function as a tumor suppressor in various cancers, yet its role in breast cancer remains unclear. This study aimed to elucidate COL6A6 expression patterns, assess i...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14680-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849226239219335168 |
|---|---|
| author | Jian-Di Li Li-Li Deng Jia-Yuan Luo Chao-Hua Mo Bang-Teng Chi Wan-Ying Huang Rong-Quan He Di-Yuan Qin Chang Song Wen Zou Gang Chen |
| author_facet | Jian-Di Li Li-Li Deng Jia-Yuan Luo Chao-Hua Mo Bang-Teng Chi Wan-Ying Huang Rong-Quan He Di-Yuan Qin Chang Song Wen Zou Gang Chen |
| author_sort | Jian-Di Li |
| collection | DOAJ |
| description | Abstract Background Collagen type VI alpha 6 chain (COL6A6), an essential component of epithelial cell basal lamina, is hypothesized to function as a tumor suppressor in various cancers, yet its role in breast cancer remains unclear. This study aimed to elucidate COL6A6 expression patterns, assess its impact on the tumor immune microenvironment, and uncover underlying molecular mechanisms in breast cancer progression. Methods Immunohistochemical staining of COL6A6 was conducted on 136 breast cancer tissues and 50 non-breast-cancer controls in-house. Global microarray and high-throughput sequencing datasets were analyzed to confirm mRNA expression trends, supported by single-cell RNA sequencing for expression intensity and distribution. Prognostic evaluation utilized a multicenter cohort of breast cancer patients through Kaplan–Meier survival and decision curve analyses. Tumor deconvolution and gene set enrichment analyses predicted COL6A6’s association with the tumor immune microenvironment and its molecular mechanisms. Mouse models, spatial transcriptomic sequencing, and transcriptional regulation analyses were employed to elucidate the intimate relationship between COL6A6 expression and immune cell distribution. Potential therapeutic agents for breast cancer patients were predicted by targeting the COL6A6 protein. Results COL6A6 protein staining intensity was significantly lower in breast cancer tissues compared to normal breast tissues (p < 0.0001). Integrated analysis confirmed COL6A6 downregulation in 4818 breast cancer tissues versus 1236 non-breast-cancer tissues (standardized mean difference = − 1.27 [− 1.66, − 0.87]), supported by single-cell RNA sequencing. Reduced COL6A6 mRNA expression moderately discriminated breast cancer from non-breast-cancer tissues (pooled area under the curve = 0.88, sensitivity = 84.85%, specificity = 72.68%). Decreased COL6A6 expression correlated with poorer overall and relapse-free survival. It had a negative correlation with the purity of the tumor but a positive correlation with the quantity of stromal and immune cells in the tumor microenvironment. Immune regulatory pathways such as adaptive immune response, T cell differentiation, T cell proliferation, macrophage activation, and natural killer cell-mediated cytotoxicity were associated with the gene sets that were enriched in the analysis. Immune-related biological processes, such as immunoglobulin production, generation of immune response mediators, myeloid leukocyte activation, leukocyte chemotaxis, and neutrophil migration, were significantly enriched in mouse models immunized with a COL6A6 peptide vaccine. The downregulation of COL6A6 was associated with reduced immune cell infiltration in malignant regions of breast cancer tissue slices, which might be negatively regulated by the CBX2 transcription factor. MK-886 may serve as a promising therapeutic agent for breast cancer treatment by targeting COL6A6 (Vina score = − 8.0). Conclusions COL6A6 may operate as a tumor suppressor in breast cancer, underscoring its correlation with immune activity in the tumor microenvironment. These findings suggest COL6A6 as a promising therapeutic target and prognostic biomarker warranting further investigation. |
| format | Article |
| id | doaj-art-cd31572adc404e779558227ce78f3637 |
| institution | Kabale University |
| issn | 1471-2407 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Cancer |
| spelling | doaj-art-cd31572adc404e779558227ce78f36372025-08-24T11:34:39ZengBMCBMC Cancer1471-24072025-08-0125111610.1186/s12885-025-14680-1The role of collagen type VI alpha 6 chain as a potential tumor suppressor in breast cancer: an immune regulation perspectiveJian-Di Li0Li-Li Deng1Jia-Yuan Luo2Chao-Hua Mo3Bang-Teng Chi4Wan-Ying Huang5Rong-Quan He6Di-Yuan Qin7Chang Song8Wen Zou9Gang Chen10Department of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Clinical Oncology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, Xiaolan People’s Hospital of ZhongshanDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Clinical Oncology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Computer Science and Technology, School of Computer and Electronic Information, Guangxi UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityAbstract Background Collagen type VI alpha 6 chain (COL6A6), an essential component of epithelial cell basal lamina, is hypothesized to function as a tumor suppressor in various cancers, yet its role in breast cancer remains unclear. This study aimed to elucidate COL6A6 expression patterns, assess its impact on the tumor immune microenvironment, and uncover underlying molecular mechanisms in breast cancer progression. Methods Immunohistochemical staining of COL6A6 was conducted on 136 breast cancer tissues and 50 non-breast-cancer controls in-house. Global microarray and high-throughput sequencing datasets were analyzed to confirm mRNA expression trends, supported by single-cell RNA sequencing for expression intensity and distribution. Prognostic evaluation utilized a multicenter cohort of breast cancer patients through Kaplan–Meier survival and decision curve analyses. Tumor deconvolution and gene set enrichment analyses predicted COL6A6’s association with the tumor immune microenvironment and its molecular mechanisms. Mouse models, spatial transcriptomic sequencing, and transcriptional regulation analyses were employed to elucidate the intimate relationship between COL6A6 expression and immune cell distribution. Potential therapeutic agents for breast cancer patients were predicted by targeting the COL6A6 protein. Results COL6A6 protein staining intensity was significantly lower in breast cancer tissues compared to normal breast tissues (p < 0.0001). Integrated analysis confirmed COL6A6 downregulation in 4818 breast cancer tissues versus 1236 non-breast-cancer tissues (standardized mean difference = − 1.27 [− 1.66, − 0.87]), supported by single-cell RNA sequencing. Reduced COL6A6 mRNA expression moderately discriminated breast cancer from non-breast-cancer tissues (pooled area under the curve = 0.88, sensitivity = 84.85%, specificity = 72.68%). Decreased COL6A6 expression correlated with poorer overall and relapse-free survival. It had a negative correlation with the purity of the tumor but a positive correlation with the quantity of stromal and immune cells in the tumor microenvironment. Immune regulatory pathways such as adaptive immune response, T cell differentiation, T cell proliferation, macrophage activation, and natural killer cell-mediated cytotoxicity were associated with the gene sets that were enriched in the analysis. Immune-related biological processes, such as immunoglobulin production, generation of immune response mediators, myeloid leukocyte activation, leukocyte chemotaxis, and neutrophil migration, were significantly enriched in mouse models immunized with a COL6A6 peptide vaccine. The downregulation of COL6A6 was associated with reduced immune cell infiltration in malignant regions of breast cancer tissue slices, which might be negatively regulated by the CBX2 transcription factor. MK-886 may serve as a promising therapeutic agent for breast cancer treatment by targeting COL6A6 (Vina score = − 8.0). Conclusions COL6A6 may operate as a tumor suppressor in breast cancer, underscoring its correlation with immune activity in the tumor microenvironment. These findings suggest COL6A6 as a promising therapeutic target and prognostic biomarker warranting further investigation.https://doi.org/10.1186/s12885-025-14680-1Breast cancerCOL6A6Immunohistochemical stainingscRNA-seqTumor microenvironmentGSEA |
| spellingShingle | Jian-Di Li Li-Li Deng Jia-Yuan Luo Chao-Hua Mo Bang-Teng Chi Wan-Ying Huang Rong-Quan He Di-Yuan Qin Chang Song Wen Zou Gang Chen The role of collagen type VI alpha 6 chain as a potential tumor suppressor in breast cancer: an immune regulation perspective BMC Cancer Breast cancer COL6A6 Immunohistochemical staining scRNA-seq Tumor microenvironment GSEA |
| title | The role of collagen type VI alpha 6 chain as a potential tumor suppressor in breast cancer: an immune regulation perspective |
| title_full | The role of collagen type VI alpha 6 chain as a potential tumor suppressor in breast cancer: an immune regulation perspective |
| title_fullStr | The role of collagen type VI alpha 6 chain as a potential tumor suppressor in breast cancer: an immune regulation perspective |
| title_full_unstemmed | The role of collagen type VI alpha 6 chain as a potential tumor suppressor in breast cancer: an immune regulation perspective |
| title_short | The role of collagen type VI alpha 6 chain as a potential tumor suppressor in breast cancer: an immune regulation perspective |
| title_sort | role of collagen type vi alpha 6 chain as a potential tumor suppressor in breast cancer an immune regulation perspective |
| topic | Breast cancer COL6A6 Immunohistochemical staining scRNA-seq Tumor microenvironment GSEA |
| url | https://doi.org/10.1186/s12885-025-14680-1 |
| work_keys_str_mv | AT jiandili theroleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT lilideng theroleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT jiayuanluo theroleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT chaohuamo theroleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT bangtengchi theroleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT wanyinghuang theroleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT rongquanhe theroleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT diyuanqin theroleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT changsong theroleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT wenzou theroleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT gangchen theroleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT jiandili roleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT lilideng roleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT jiayuanluo roleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT chaohuamo roleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT bangtengchi roleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT wanyinghuang roleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT rongquanhe roleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT diyuanqin roleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT changsong roleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT wenzou roleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective AT gangchen roleofcollagentypevialpha6chainasapotentialtumorsuppressorinbreastcanceranimmuneregulationperspective |